Not applicableStudy completedNCT05988047What this trial is testingAnalysis of CMTM6 Expression in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia, Adult University of Freiburg 150
Testing effectiveness (Phase 2)Looking for participantsNCT07046078What this trial is testingCombination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid CancerWho this might be right forAcute Leukemia of Ambiguous LineageAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+1 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT02723435What this trial is testingMidostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-TransplantWho this might be right forAcute Myeloid Leukemia With Gene MutationsAdult Acute Myeloid Leukemia in Remission Stanford University
Large-scale testing (Phase 3)Study completedNCT00492856What this trial is testingS0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic LeukemiaWho this might be right forLeukemia SWOG Cancer Research Network 105
Not applicableNo Longer AvailableNCT02624570What this trial is testingMidostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation ChemotherapyWho this might be right forAcute Myeloid Leukemia (AML) WithFLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD) Novartis Pharmaceuticals
Large-scale testing (Phase 3)UnknownNCT03846362What this trial is testingA Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AMLWho this might be right forAcute Myeloid Leukemia, Childhood Federal Research Institute of Pediatric Hematology, Oncology and Immunology 500
Early research (Phase 1)Ended earlyNCT00618696What this trial is testingYttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced LeukemiaWho this might be right forLeukemiaMyelodysplastic Syndromes Masonic Cancer Center, University of Minnesota 4
Testing effectiveness (Phase 2)Ended earlyNCT03063203What this trial is testingSingle Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Myeloid Leukemia, Relapsed, Adult Washington University School of Medicine 17
Testing effectiveness (Phase 2)UnknownNCT05404516What this trial is testingCombination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AMLWho this might be right forCore Binding Factor Acute Myeloid Leukemia Nanfang Hospital, Southern Medical University 88
Testing effectiveness (Phase 2)Study completedNCT00588809What this trial is testingSelumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)Myelodysplastic Syndromes+3 more National Cancer Institute (NCI) 47
Not applicableStudy completedNCT00005799What this trial is testingFludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more Fred Hutchinson Cancer Center 55
Early research (Phase 1)Study completedNCT00008177What this trial is testingRadiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+14 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02144675What this trial is testingCholine Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+14 more Rutgers, The State University of New Jersey 27
Large-scale testing (Phase 3)Study completedNCT00322101What this trial is testingLow-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous LeukemiaWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAdult Acute Myeloid Leukemia in Remission+16 more Fred Hutchinson Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT02270463What this trial is testingSL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete RemissionWho this might be right forAcute Myeloid Leukemia Stemline Therapeutics, Inc. 16
Early research (Phase 1)Ended earlyNCT05153330What this trial is testingStudy of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLLWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Mixed-Phenotype Leukemia+12 more Biomea Fusion Inc. 55
Early research (Phase 1)WithdrawnNCT05521087What this trial is testingJNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasWho this might be right forAcute LeukemiasAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more Janssen Research & Development, LLC
Testing effectiveness (Phase 2)WithdrawnNCT00003407What this trial is testingAmifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CMLWho this might be right forDrug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more Rush University Medical Center
Not applicableUnknownNCT03260101What this trial is testingNon-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 StudyWho this might be right forAcute Myelogenous Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Non Hodgkin Lymphoma (NHL)+1 more Cellect Biotechnology 12
Testing effectiveness (Phase 2)Study completedNCT00313586What this trial is testingAzacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+12 more National Cancer Institute (NCI) 197